Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Tizanidine HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 14 USDMF, 1 CEP/COS, 6 JDMF, 5 EU WC, 3 KDMF, 9 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers, 76 FDA Orange Book, 9 Europe, 2 Canada, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 2MG BASE, CAPSULE;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 6MG BASE

RELATED EXCIPIENT COMPANIES

2 Evonik, 4 SPI Pharma, 10 DKSH, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 2 Kirsch Pharma, 4 ACG Worldwide, 1 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 1 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 24 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 42 Fillers, Diluents & Binders, 28 Direct Compression, 25 Granulation, 22 Thickeners and Stabilizers, 17 Controlled & Modified Release, 17 Disintegrants & Superdisintegrants, 13 Taste Masking, 10 Film Formers & Plasticizers, 10 Co-Processed Excipients, 9 Lubricants & Glidants, 9 Empty Capsules, 8 Chewable & Orodispersible Aids, 5 Coloring Agents, 5 Emulsifying Agents, 5 Topical, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Solubilizers, 3 Parenteral, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 24 News #PharmaBuzz

GLOBAL SALES INFORMATION

20 US Medicaid Prescriptions, 8 Regulatory FDF Prices

MARKET PLACE

12 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	FARMAK, a.s	Czech Republic	Kwangdong Pharmaceutical Co., Ltd.	20210421-209-J-493(1)	tizanidine hydrochloride	2021-06-21	Farmak, as	Czech Republic	Na vlcinci 16/3, Klasterni Hradisko, 779 00 Olomouc, Czech Republic
29/11/2025	FARMAK, a.s	Czech Republic	Classia Co., Ltd.	20210421-209-J-493	tizanidine hydrochloride	2021-04-21	Farmak, as	Czech Republic	Na vlcinci 16/3, Klasterni Hradisko, 779 00 Olomouc, Czech Republic

Tizanidine HCl

Tizanidine HCl

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers

14 USDMF

1 CEP/COS

6 JDMF

5 EU WC

3 KDMF

9 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers

76 FDA Orange Book

9 Europe

2 Canada

27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 4MG BASE

CAPSULE;ORAL - EQ 2MG BASE

CAPSULE;ORAL - EQ 4MG BASE

CAPSULE;ORAL - EQ 6MG BASE

RELATED EXCIPIENT COMPANIES

2 Evonik

4 SPI Pharma

10 DKSH

4 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Pfanstiehl

2 Kirsch Pharma

4 ACG Worldwide

1 Actylis

1 Aeon Procare

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 BASF

10 Corel Pharma Chem

6 DFE Pharma

3 Doshion Polyscience

1 Finar

6 Gangwal Chemicals

4 Ideal Cures

3 Ingredion Pharma Solutions

24 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

8 Microlex e.U

1 Nitika Pharmaceutical Specialities

1 Novo Excipients

1 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

18 Roquette

8 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

2 Silverline Chemicals

2 The Dow Chemical Company

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives

42 Fillers, Diluents & Binders

28 Direct Compression

25 Granulation

22 Thickeners and Stabilizers

17 Controlled & Modified Release

17 Disintegrants & Superdisintegrants

TABLET;ORAL - EQ 2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons